发明名称 dabigatran-etexilate et ses sels- particulièrement dabigatran-etexilate-mésilate (PRADAXA)
摘要 The invention relates to new disubstituted bicyclic heterocycles of the general formula (I): Ra-A-Het-B-Ar-E, in which A, B, Ar, Het and Ra are defined as in claim 1. The invention also relates to their tautomers, their stereoisomers, their mixtures, and their salts, which have valuable properties. The compounds of the above general formula (I), in which E is a cyano group, thus represent valuable intermediate products for the production of the other compounds of the general formula (I). Furthermore, the compounds of the above general formula (I), in which E stands for a RbNH-C(=NH)-group, have valuable pharmacological properties, in particular in inhibiting thrombin and prolonging thrombin time.
申请公布号 LU91437(I2) 申请公布日期 2008.07.14
申请号 LU20080091437C 申请日期 2008.05.14
申请人 BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG 发明人
分类号 C07D239/74;A61K31/404;A61K31/4184;A61K31/4188;A61K31/425;A61K31/437;A61K31/4439;A61K31/444;A61K31/454;A61K31/465;A61K31/498;A61K31/501;A61K31/506;A61K31/517;A61P7/02;A61P9/14;C07D209/08;C07D209/14;C07D235/06;C07D235/12;C07D235/14;C07D235/16;C07D235/28;C07D241/44;C07D277/64;C07D277/74;C07D401/12;C07D401/14;C07D403/12;C07D409/06;C07D409/14;C07D417/12;C07D471/04;C07D495/04;C07D513/04 主分类号 C07D239/74
代理机构 代理人
主权项
地址